Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.

Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, Tauscher J, Hilger E, Stastny J, Brücke T, Kasper S.

Biol Psychiatry. 2000 Mar 15;47(6):482-9.

PMID:
10715354
2.

Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.

Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T.

J Nucl Med. 2000 Jan;41(1):36-44.

3.

[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa.

Tauscher J, Pirker W, Willeit M, de Zwaan M, Bailer U, Neumeister A, Asenbaum S, Lennkh C, Praschak-Rieder N, Brücke T, Kasper S.

Biol Psychiatry. 2001 Feb 15;49(4):326-32.

PMID:
11239903
4.

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.

Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS.

Biol Psychiatry. 1998 Dec 1;44(11):1090-8.

PMID:
9836013
5.
6.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
7.

Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.

Kim SE, Choi JY, Choe YS, Choi Y, Lee WY.

J Nucl Med. 2003 Jun;44(6):870-6.

8.

No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism.

Willeit M, Stastny J, Pirker W, Praschak-Rieder N, Neumeister A, Asenbaum S, Tauscher J, Fuchs K, Sieghart W, Hornik K, Aschauer HN, Brücke T, Kasper S.

Biol Psychiatry. 2001 Jul 1;50(1):8-12.

PMID:
11457418
9.

Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.

Pogarell O, Hamann C, Pöpperl G, Juckel G, Choukèr M, Zaudig M, Riedel M, Möller HJ, Hegerl U, Tatsch K.

Biol Psychiatry. 2003 Dec 15;54(12):1406-13.

PMID:
14675805
10.

Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.

Ruhé HG, Booij J, Reitsma JB, Schene AH.

Eur J Nucl Med Mol Imaging. 2009 May;36(5):841-9. doi: 10.1007/s00259-008-1057-x. Epub 2009 Jan 30.

PMID:
19183998
11.

[123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.

Zitterl W, Aigner M, Stompe T, Zitterl-Eglseer K, Gutierrez-Lobos K, Schmidl-Mohl B, Wenzel T, Demal U, Zettinig G, Hornik K, Thau K.

Neuropsychopharmacology. 2007 Aug;32(8):1661-8. Epub 2006 Dec 27.

12.

Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls.

Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, Pirker W, Konstantinidis A, Kasper S.

Psychol Med. 2001 Nov;31(8):1467-73.

PMID:
11722161
13.

Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).

Stengler-Wenzke K, Müller U, Angermeyer MC, Sabri O, Hesse S.

Eur Arch Psychiatry Clin Neurosci. 2004 Aug;254(4):252-5.

PMID:
15309396
14.

Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.

Seppi K, Scherfler C, Donnemiller E, Virgolini I, Schocke MF, Goebel G, Mair KJ, Boesch S, Brenneis C, Wenning GK, Poewe W.

Arch Neurol. 2006 Aug;63(8):1154-60.

PMID:
16908744
15.

Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging.

Joensuu M, Tolmunen T, Saarinen PI, Tiihonen J, Kuikka J, Ahola P, Vanninen R, Lehtonen J.

Psychiatry Res. 2007 Feb 28;154(2):125-31. Epub 2007 Feb 7.

PMID:
17289353
16.

beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo.

Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, Deecke L, Podreka I, Brücke T.

J Neural Transm Gen Sect. 1995;100(3):247-56.

PMID:
8748670
17.

Sex differences in diencephalon serotonin transporter availability in major depression.

Staley JK, Sanacora G, Tamagnan G, Maciejewski PK, Malison RT, Berman RM, Vythilingam M, Kugaya A, Baldwin RM, Seibyl JP, Charney D, Innis RB.

Biol Psychiatry. 2006 Jan 1;59(1):40-7. Epub 2005 Sep 1.

PMID:
16139815
18.

Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]beta-CIT SPECT analysis.

Scherfler C, Boesch SM, Donnemiller E, Seppi K, Weirich-Schwaiger H, Goebel G, Virgolini I, Wenning GK, Poewe W.

Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1084-90. Epub 2006 May 13.

PMID:
16699769
19.

Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.

Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, Maciejewski PK, O'Malley S, Innis RB.

Synapse. 2001 Sep 15;41(4):275-84.

PMID:
11494398
20.

Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.

Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, Wenning GK, Poewe W.

Brain. 2005 Jul;128(Pt 7):1605-12. Epub 2005 Apr 7.

Items per page

Supplemental Content

Write to the Help Desk